NCT06251778View on ClinicalTrials.gov

NatiOnal Referral cenTEr Study of Transthyretin Amyloid Cardiomyopathy(ATTR) Patients on Tafamidis

RecruitingOBSERVATIONAL

Enrollment

200

Participants

Timeline

Start Date

January 26, 2024

Primary Completion Date

January 26, 2026

Study Completion Date

January 26, 2026

Conditions

AmyloidosisAmyloidosis CardiacATTR Amyloidosis Wild Type

Trial Locations (1)

27100

RECRUITING

Fondazione IRCCS Policlinico San Matteo, Pavia

All Listed Sponsors

lead

Paolo Milani

OTHER